Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05736146 · ClinicalTrials.gov registry record
Validating Gulf War Illness Blood Biomarkers
A clinical trial of Gulf War Illness and Gulf War Syndrome, sponsored by Roskamp Institute.
- Recruiting
- Registry status
- 100
- Enrollment target
- 3
- Study locations
NCT05736146: Recruiting study of Gulf War Illness and Gulf War Syndrome, sponsored by Roskamp Institute.
NCT05736146 is a study of Gulf War Illness and Gulf War Syndrome that is actively recruiting participants, run by Roskamp Institute. The registered enrollment target is 100 participants, below the 123-participant average among 14 other Gulf War Illness trials with a reported enrollment target (19% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05736146, a study of Gulf War Illness and Gulf War Syndrome, is actively recruiting participants, sponsored by Roskamp Institute.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators goals are to identify blood lipids/metabolites that correlate with cognitive decline in the presence of the APOE ε4 allele among veterans with GWI. To determine the effect of dietary, medical and biological factors that influence lipid and metabolites in blood from GW veterans. To identify blood lipid/metabolite profiles that correlate with bioenergetics deficits and glial activation in the brains of GWI. To validate blood biomarker signatures of GWI using APOE genotyping and blood lipids/metabolites that correlate with the CNS dysfunction in GWI.
Primary Outcome
To validate blood biomarker signatures of GWI using APOE genotyping and blood lipids/metabolites that correlate with the CNS dysfunction in GWI.
Conditions Studied
Study Locations (3)
California
- Palto Alto Veterans Institute for Research - Palo Alto
Florida
- The Roskamp Institute - Sarasota
Massachusetts
- Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-06-30 |
| Est. Completion | 2026-03-01 |
What NCT05736146 shows while recruiting
NCT05736146 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 123-participant average among 14 other Gulf War Illness trials with a reported enrollment target (19% lower).
The record links to 2 conditions, with Gulf War Illness appearing as the primary indexed condition, and to 0 interventions.
NCT05736146 reports a single indexed study location in California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05736146 about?
NCT05736146 is a clinical study titled "Validating Gulf War Illness Blood Biomarkers". The investigators goals are to identify blood lipids/metabolites that correlate with cognitive decline in the presence of the APOE ε4 allele among veterans with GWI. To determine the effect of dietary, medical and biological factors that influence lipid and metabolites in blood from GW veterans. To ...
What is the current status of trial NCT05736146?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-06-30. Estimated completion is 2026-03-01.
What conditions does trial NCT05736146 study?
This clinical trial studies the following conditions: Gulf War Illness, Gulf War Syndrome.
Who is sponsoring clinical trial NCT05736146?
This trial is sponsored by Roskamp Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05736146 being conducted?
This trial has 3 study locations across California, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05736146's enrollment target sits among peer trials
100 6th of 14 higher than 8 of 14 other Gulf War Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gulf War Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Confirmation of Diet as a Treatment for Gulf War Illness
RECRUITING · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
-
Ca-Mg Butyrate in GWI
RECRUITING · Phase 2
-
Mechanisms of Gulf War Illness
RECRUITING · NA
-
Study of Bacopa in Gulf War Illness Patients
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI